New Tackling Cholesterol Together education programme launches with cholesterol charity HEART UK

Tackling Cholesterol Together Logo

The NHS Accelerated Access Collaborative (AAC) and The AHSN Network are partnering with the cholesterol charity, HEART UK, to launch a new education programme for healthcare professionals called Tackling Cholesterol Together.

The Tackling Cholesterol Together programme will support the NHS Long Term Plan which includes a major ambition to prevent 150,000 heart attacks, strokes and dementia cases over the next 10 years by improving the treatment of high-risk conditions, known as ‘the ABC’ – atrial fibrillation (A), high blood pressure (B) and high cholesterol (C).

Led by a team of national clinical leaders and experts in cardiovascular disease (CVD), the programme will promote CVD prevention against a backdrop of it remaining the leading cause of premature mortality in England.

It will be delivered through a blend of videos, podcasts, webinars, expert clinics and online modules; and will cover topics ranging from statin intolerance to behavioural change, Familial Hypercholesterolaemia (FH), novel therapies on the horizon, and much more.

The programme will support healthcare professionals to address under diagnosis and under treatment at scale and use new models to manage cholesterol, underpinned by an updated NICE endorsed pathway, with certificates issued for completion of all content.

Shahed Ahmad, National Clinical Director for Cardiovascular Disease Prevention at NHS England and Improvement said: “Cardiovascular Disease kills 136,000 people a year; a similar number to the number of deaths we have had from Covid. Prevention is at the heart of the Long-Term Plan. The national ambitions for CVD prevention in the NHS in England aim to reduce inequalities, close the gap in life expectancy and save lives.”

The education programme supports The AHSN Network, AAC 3-year lipids workstream including the Lipid Management Rapid Uptake Products programme and the Lipid Management and FH programme with the aim to boost uptake of the medicines in the updated NICE endorsed pathways, including new NICE recommended therapies.

For more information and access to content which is now available, please go to

Back to top